Thursday, June 8, 2023
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Professor of Public Health
Honorary Consultant Cardiologist
Imperial Centre for Cardiovascular Disease Prevention
Department of Primary Care & Public Health
Imperial College London
London, United Kingdom
Irving Professor of Medicine
Director Emeritus
Irving Institute for Clinical and Translational Research
Columbia University
New York, New York
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
This activity is intended for physicians, i.e, diabetologists and endocrinologists, cardiologists, primary care clinicians, nurses, and pharmacists who provide care for patients with cardiovascular disease (CVD) and who are at high risk for or with type 2 diabetes (T2D).
The goal of this activity is for learners to be better able to determine the appropriate use of statins to treat dyslipidemia in patients with CVD who are at high risk for or with T2D.
Upon completion of this activity, participants will:
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Professor of Public Health
Honorary Consultant Cardiologist
Imperial Centre for Cardiovascular Disease Prevention
Department of Primary Care & Public Health
Imperial College London
London, United Kingdom
Irving Professor of Medicine
Director Emeritus
Irving Institute for Clinical and Translational Research
Columbia University
New York, New York
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0.50 contact hours are in the area of pharmacology.
Medscape designates this continuing education activity for 0.50 contact hour(s) (0.050 CEUs) (Universal Activity Number JA0007105-0000-18-148-H01-P).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 7/31/2018
Valid for credit through: 7/31/2019
processing....
ACC = American College of Cardiology
ACE = angiotensin-converting enzyme
ACS = acute coronary syndrome
ALT = alanine aminotransferase
apoB = apolipoprotein B
ART = antiretroviral therapy
ASCVD = atherosclerotic cardiovascular disease
AST = aspartate aminotransferase
AUC = area under the curve
BMI = body mass index
BP = blood pressure
CABG = coronary artery bypass grafting
CAD - coronary artery disease
CHD = coronary heart disease
CHF = congestive heart failure
CI = confidence interval
CV = cardiovascular
CVD = cardiovascular disease
DAPT = dual antiplatelet therapy
DM = diabetes mellitus
FDA = US Food and Drug Administration
FH = family history
GLP-1 = glucagon-like peptide 1
HbA1c = glycated hemoglobin
HDL = high-density lipoprotein
HDL-C = high-density lipoprotein cholesterol
HI = high-intensity statin therapy
HIV = human immunodeficiency virus
HMGCR = 3-hydroxy-3-methylglutaryl-CoA reductase
INR = international normalized ratio
LDL = low-density lipoprotein
LDL-C = low-density lipoprotein-cholesterol
LMI = low-moderate intensity statin therapy
MACE = major adverse cardiac events
MI = myocardial infarction
NHIS = National Health Interview Survey
NNT = number needed to treat
OR = odds ratio
OTC = over-the-counter
PAD = peripheral artery disease
PCI = percutaneous coronary intervention
RCT = randomized controlled trial
RR = relative risk
RRR = relative risk reduction
SGLT2 = sodium glucose cotransporter-2
STEMI = ST-elevation myocardial infarction
TC = total cholesterol
TG = triglycerides
TIA = transient ischemic attack
T2DM = type 2 diabetes mellitus
TLR = target lesion revascularization
UA = unstable angina
ULN = upper limit of normal
Vd = volume of distribution
| « Return to: Statins, Diabetes and Glucose Metabolism: Challenging Cases and Considerations |
